US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist

3.2700
-0.3900-10.66%

Close Nov 27 16:00 ET

7.75MMarket Cap-485P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-23.74%11.81M

30.54%15.48M

415.82%11.86M

-45.21%2.3M

21.69%4.2M

-40.19%3.45M

5.77M

Selling and administrative expenses

-9.33%5.9M

9.50%6.51M

170.08%5.94M

-33.32%2.2M

20.39%3.3M

90.05%2.74M

--1.44M

-General and administrative expense

-9.33%5.9M

9.50%6.51M

170.08%5.94M

-33.32%2.2M

20.39%3.3M

90.05%2.74M

--1.44M

Research and development costs

-34.18%5.91M

51.65%8.98M

5,844.42%5.92M

-88.91%99.58K

26.72%897.79K

-83.62%708.46K

--4.32M

Operating profit

23.74%-11.81M

-30.54%-15.48M

-415.82%-11.86M

45.21%-2.3M

-21.69%-4.2M

40.19%-3.45M

-5.77M

Net non-operating interest income expense

-43.91%-145.15K

-48.04%-100.87K

70.85%-68.13K

71.49%-233.7K

24.43%-819.71K

-21.82%-1.08M

-890.4K

Non-operating interest expense

43.91%145.15K

48.04%100.87K

-70.85%68.13K

-71.49%233.7K

-24.43%819.71K

21.82%1.08M

--890.4K

Other net income (expense)

75.91%-219.81K

-5,167.27%-912.45K

94.72%-17.32K

23.71%-328.37K

29.81%-430.4K

-613.2K

Special income (charges)

--0

---922.5K

--0

42.00%-364.95K

---629.23K

--0

-Less:Other special charges

----

--922.5K

----

-42.00%364.95K

--629.23K

----

Other non- operating income (expenses)

-2,288.27%-219.81K

157.99%10.05K

94.72%-17.32K

-401.74%-328.37K

-508.14%-65.45K

--16.04K

----

Income before tax

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

-6.66M

Income tax

Net income

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

-6.66M

Net income continuous Operations

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

---6.66M

Minority interest income

Net income attributable to the parent company

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

-6.66M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

26.21%-12.17M

-38.08%-16.5M

-317.49%-11.95M

47.47%-2.86M

-5.84%-5.45M

22.69%-5.15M

-6.66M

Basic earnings per share

61.90%-12.8

16.00%-33.6

-270.32%-40

41.61%-10.8016

-4,133.46%-18.4974

22.69%-0.4369

-0.5652

Diluted earnings per share

61.90%-12.8

16.00%-33.6

-270.32%-40

41.61%-10.8016

-4,133.46%-18.4974

22.69%-0.4369

-0.5652

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017
Total revenue	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-23.74%11.81M	30.54%15.48M	415.82%11.86M	-45.21%2.3M	21.69%4.2M	-40.19%3.45M	5.77M
Selling and administrative expenses	-9.33%5.9M	9.50%6.51M	170.08%5.94M	-33.32%2.2M	20.39%3.3M	90.05%2.74M	--1.44M
-General and administrative expense	-9.33%5.9M	9.50%6.51M	170.08%5.94M	-33.32%2.2M	20.39%3.3M	90.05%2.74M	--1.44M
Research and development costs	-34.18%5.91M	51.65%8.98M	5,844.42%5.92M	-88.91%99.58K	26.72%897.79K	-83.62%708.46K	--4.32M
Operating profit	23.74%-11.81M	-30.54%-15.48M	-415.82%-11.86M	45.21%-2.3M	-21.69%-4.2M	40.19%-3.45M	-5.77M
Net non-operating interest income expense	-43.91%-145.15K	-48.04%-100.87K	70.85%-68.13K	71.49%-233.7K	24.43%-819.71K	-21.82%-1.08M	-890.4K
Non-operating interest expense	43.91%145.15K	48.04%100.87K	-70.85%68.13K	-71.49%233.7K	-24.43%819.71K	21.82%1.08M	--890.4K
Other net income (expense)	75.91%-219.81K	-5,167.27%-912.45K	94.72%-17.32K	23.71%-328.37K	29.81%-430.4K	-613.2K
Special income (charges)	--0	---922.5K	--0	--0	42.00%-364.95K	---629.23K	--0
-Less:Other special charges	----	--922.5K	----	----	-42.00%364.95K	--629.23K	----
Other non- operating income (expenses)	-2,288.27%-219.81K	157.99%10.05K	94.72%-17.32K	-401.74%-328.37K	-508.14%-65.45K	--16.04K	----
Income before tax	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	-6.66M
Income tax
Net income	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	-6.66M
Net income continuous Operations	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	---6.66M
Minority interest income
Net income attributable to the parent company	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	-6.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	26.21%-12.17M	-38.08%-16.5M	-317.49%-11.95M	47.47%-2.86M	-5.84%-5.45M	22.69%-5.15M	-6.66M
Basic earnings per share	61.90%-12.8	16.00%-33.6	-270.32%-40	41.61%-10.8016	-4,133.46%-18.4974	22.69%-0.4369	-0.5652
Diluted earnings per share	61.90%-12.8	16.00%-33.6	-270.32%-40	41.61%-10.8016	-4,133.46%-18.4974	22.69%-0.4369	-0.5652
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data